On-treatment C-reactive protein and HDL cholesterol levels in patients at intermediate cardiovascular risk: Impact on carotid intima-media thickness

Life Sciences

Volumn 93, Issue 8, 2013, Pages 338-343

  Pirro, Matteo ^a   Vaudo, Gaetano ^a   Lupattelli, Graziana ^a   Pasqualini, Leonella ^a   Mannarino, Massimo R ^a   Schillaci, Giuseppe ^a   Alaeddin, Abdalkader ^a   Paciullo, Francesco ^a   Fallarino, Francesca ^a   Bagaglia, Francesco ^a   Mannarino, Elmo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Atherosclerosis; C reactive protein; Carotid; Hypercholesterolemia; Intima media thickness; Statin

Indexed keywords

ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; FEMALE; FRAMINGHAM RISK SCORE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SMOKING; WAIST CIRCUMFERENCE;

ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CAROTID; HYPERCHOLESTEROLEMIA; INTIMA-MEDIA THICKNESS; STATIN;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84883230465     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2013.07.008     Document Type: Article

References (36)

1. S.S. Anand, and S. Yusuf C-reactive protein is a bystander of cardiovascular disease Eur Heart J 31 2010 2092 2096
2. E. Androulakis, D. Tousoulis, N. Papageorgiou, G. Latsios, G. Siasos, C. Tsioufis, and A. Giolis Stefanadis. Inflammation in hypertension: current therapeutic approaches Curr Pharm Des 17 2011 4121 4131
3. P. Barter HDL-C: role as a risk modifier Atheroscler Suppl 12 2011 267 270
4. U.S. Bedi, M. Singh, P.P. Singh, R. Bhuriya, A. Bahekar, J. Molnar, S. Khosla, and R. Arora Effects of statins on progression of carotid atherosclerosis as measured by carotid intimal-medial thickness: a meta-analysis of randomized controlled trials J Cardiovasc Pharmacol Ther 15 2010 268 273
5. K.S. Cheng, D.P. Mikhailidis, G. Hamilton, and A.M. Seifalian A review of the carotid and femoral intima-media thickness as an indicator of the presence of peripheral vascular disease and cardiovascular risk factors Cardiovasc Res 54 2002 528 538
6. E. Choy, and N. Sattar Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions Ann Rheum Dis 68 2009 460 469
7. D. De Bacquer, and G. De Backer The prevalence of concomitant hypertension and hypercholesterolaemia in the general population Int J Cardiol 110 2006 217 223
8. Emerging Risk Factors Collaboration C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis Lancet 375 2010 132 140
9. M. Enomoto, H. Adachi, Y. Hirai, A. Fukami, A. Satoh, M. Otsuka, S. Kumagae, Y. Nanjo, K. Yoshikawa, E. Esaki, E. Kumagai, K. Ogata, A. Kasahara, E. Tsukagawa, K. Yokoi, K. Ohbu-Murayama, and T. Imaizumi LDL-C/HDL-C ratio predicts carotid intima-media thickness progression better than HDL-C or LDL-C alone J Lipids 2011 549137
10. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
11. K. Gokulakrishnan, R. Deepa, and V. Mohan Association of high sensitivity C-reactive protein (hsCRP) and tumour necrosis factor-alpha (TNF-alpha) with carotid intimal medial thickness in subjects with different grades of glucose intolerance - the Chennai Urban Rural Epidemiology Study (CURES-31) Clin Biochem 41 2008 480 485
12. I. Lemieux, A. Pascot, D. Prud'homme, N. Alméras, P. Bogaty, A. Nadeau, J. Bergeron, and J.P. Després Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity Arterioscler Thromb Vasc Biol 21 2001 961 967
13. M.W. Lorenz, P. Karbstein, H.S. Markus, and M. Sitzer High-sensitivity C-reactive protein is not associated with carotid intima-media progression: the carotid atherosclerosis progression study Stroke 38 2007 1774 1779
14. C. Masoura, C. Pitsavos, K. Aznaouridis, I. Skoumas, C. Vlachopoulos, and C. Stefanadis Arterial endothelial function and wall thickness in familial hypercholesterolemia and familial combined hyperlipidemia and the effect of statins A systematic review and meta-analysis Atherosclerosis 214 2011 129 138
15. E.J. Mills, P. Wu, G. Chong, I. Ghement, S. Singh, E.A. Akl, O. Eyawo, G. Guyatt, O. Berwanger, and M. Briel Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials QJM 104 2011 109 124
16. M. Navab, S.T. Reddy, B.J. Van Lenten, and A.M. Fogelman HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms Nat Rev Cardiol 8 2011 222 232
17. D.H. O'Leary, and M.L. Bots Imaging of atherosclerosis: carotid intima-media thickness Eur Heart J 31 2010 1682 1689
18. E. Paffen, and M.P. DeMaat C-reactive protein in atherosclerosis: a causal factor? Cardiovasc Res 71 2006 30 39
19. P. Paramsothy, R.H. Knopp, A.G. Bertoni, R.S. Blumenthal, B.A. Wasserman, M.Y. Tsai, T. Rue, N.D. Wong, and S.R. Heckbert Association of combinations of lipid parameters with carotid intima-media thickness and coronary artery calcium in the MESA (Multi-Ethnic Study of Atherosclerosis) J Am Coll Cardiol 56 2010 1034 1041
20. A. Paul, E.T. Yeh, and L. Chan A proatherogenic role for C-reactive protein in vivo Curr Opin Lipidol 16 2005 512 517
21. T.A. Pearson, G.A. Mensah, R.W. Alexander, J.L. Anderson, R.O. Cannon III, M. Criqui, Y.Y. Fadl, S.P. Fortmann, Y. Hong, G.L. Myers, N. Rifai, S.C. Smith Jr., K. Taubert, R.P. Tracy, and F. Vinicor Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association Circulation 107 2003 499 511
22. M. Pirro, J. Bergeron, G.R. Dagenais, P.M. Bernard, B. Cantin, J.P. Després, and B. Lamarche (2001) Age and duration of follow-up as modulators of the risk for ischemic heart disease associated with high plasma C-reactive protein levels in men Arch Intern Med 161 2001 2474 2480
23. M. Pirro, D. Siepi, G. Lupattelli, A.R. Roscini, G. Schillaci, F. Gemelli, G. Vaudo, S. Marchesi, L. Pasqualini, and E. Mannarino Plasma C-reactive protein in subjects with hypo/hyperalphalipoproteinemias Metabolism 52 2003 432 436
24. P.M. Ridker C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus J Am Coll Cardiol 49 2007 2129 2138
25. P.M. Ridker, J.E. Buring, N. Rifai, and N.R. Cook Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score JAMA 297 2007 611 619
26. P.M. Ridker, N.P. Paynter, N. Rifai, J.M. Gaziano, and N.R. Cook C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men Circulation 118 2008 2243 2251
27. G. Schillaci, and M. Pirro C-reactive protein in hypertension: clinical significance and predictive value Nutr Metab Cardiovasc Dis 16 2006 500 508
28. G. Schillaci, M. Pirro, F. Gemelli, L. Pasqualini, G. Vaudo, S. Marchesi, D. Siepi, F. Bagaglia, and E. Mannarino Increased C-reactive protein concentrations in never-treated hypertension: the role of systolic and pulse pressures J Hypertens 21 2003 1841 1846
29. P.K. Shah Residual risk and high-density lipoprotein cholesterol levels: is there a relationship? Rev Cardiovasc Med 12 2011 e55 e59
30. M. Sitzer, H.S. Markus, M.A. Mendall, R. Liehr, U. Knorr, and H. Steinmetz C-reactive protein and carotid intimal medial thickness in a community population J Cardiovasc Risk 9 2002 97 103
31. A.C. St-Pierre, B. Cantin, J. Bergeron, M. Pirro, G.R. Dagenais, J.P. Després, and B. Lamarche Inflammatory markers and long-term risk of ischemic heart disease in men: a 13-year follow-up of the Quebec Cardiovascular Study Atherosclerosis 182 2005 315 321
32. T.C. Su, J.S. Jeng, K.L. Chien, F.C. Sung, H.C. Hsu, and Y.T. Lee Hypertension status is the major determinant of carotid atherosclerosis: a community-based study in Taiwan Stroke 32 2001 2265 2271
33. A.H. Thakore, C.Y. Guo, M.G. Larson, D. Corey, T.J. Wang, R.S. Vasan, R.B. D'Agostino Sr., I. Lipinska, J.F. Keaney Jr., E.J. Benjamin, and C.J. O'Donnell Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study) Am J Cardiol 99 2007 1598 1602
34. A.I. Tropeano, N. Saleh, N. Hawajri, I. Macquin-Mavier, and P. Maison Do all antihypertensive drugs improve carotid intima-media thickness? A network meta-analysis of randomized controlled trials Fundam Clin Pharmacol 25 2011 395 404
35. G. Vaudo, G. Schillaci, F. Evangelista, L. Pasqualini, P. Verdecchia, and E. Mannarino Arterial wall thickening at different sites and its association with left ventricular hypertrophy in newly diagnosed essential hypertension Am J Hypertens 13 2000 324 331
36. G. Vaudo, S. Marchesi, D. Siepi, M. Brozzetti, M.R. Mannarino, M. Pirro, G. Schillaci, G. Ciuffetti, G. Lupattelli, and E. Mannarino Metabolic syndrome and preclinical atherosclerosis: focus on femoral arteries Metabolism 56 2007 541 546